Do not stop or change your medication without speaking to a pharmacist or healthcare professional.

This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Permanently Discontinued

TEVA-NAPROXEN

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TEVA-NAPROXEN in Canada?

Yes. TEVA-NAPROXEN 250MG has an active shortage reported to Health Canada (last updated July 31, 2026).

Why is TEVA-NAPROXEN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will TEVA-NAPROXEN be available again?

The estimated resolution date (July 31, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products
Affected strength250MG
Last updated2017-06-27

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

NAPROSYN 250MG

SYNTEX INC.

250MG · DIN 00335193

Same strengthSame dosage formSame routeNo current shortage

NU-NAPROX TAB 250MG

NU-PHARM INC

250MG · DIN 00865648

Same strengthSame dosage formSame routeNo current shortage

Other Products

NAPROSYN 375MG

SYNTEX INC.

375MG · DIN 00583367

Different strengthSame dosage formSame routeNo current shortage

RATIO-NAPROXEN

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

500MG · DIN 00615331

Different strengthSame dosage formSame routeNo current shortage

SYNFLEX TAB 275MG

ALTIMED PHARMA INC.

275MG · DIN 00675369

Different strengthSame dosage formSame routeNo current shortage

ANAPROX

SYNTEX INC.

275MG · DIN 00491772

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

00565350

Strength

250MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

NAPROXEN

Tier

Unrated

Last Updated

2017-06-27

Reason for Shortage

Business reasons

Past Reports for This Drug

TEVA-NAPROXEN has 2 shortage/discontinuation reports on file — this is one of them.